
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (21): 2586-2591.DOI: 10.12114/j.issn.1007-9572.2023.0309
• Original Research • Previous Articles Next Articles
Received:2022-11-28
Revised:2023-08-22
Published:2024-07-20
Online:2024-04-18
Contact:
ZHANG Dongliang
通讯作者:
张东亮
作者简介:作者贡献:
张东亮负责课题设计和组织研究,参与数据整理、统计分析、论文撰写,对论文整体负责;马迎春、任建伟、王磊、赵景新、吝许亚负责所在分中心患者随访及数据收集。
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0309
| 项目 | MHD组(n=176) | PD组(n=135) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄(岁) | 57.8±15.1 | 57.3±16.7 | 0.251 | 0.802 |
| 性别(男/女) | 108/68 | 74/61 | 1.350a | 0.249 |
| 透析龄[M(P25,P75),月] | 17.82(10.10,32.85) | 17.00(6.00,27.00) | 1.573b | 0.014 |
| 身高(cm) | 166.7±8.5 | 165.0±8.6 | 1.695 | 0.091 |
| BW(kg) | 67.7±14.6 | 64.2±13.9 | 2.116 | 0.035 |
| TW(kg) | 64.9±14.3 | 60.5±13.4 | 2.728 | 0.007 |
| BMI(kg/m2) | 24.3±4.5 | 23.5±3.8 | 1.696 | 0.091 |
| SBP(mmHg) | 151±19 | 147±22 | 1.508 | 0.132 |
| DBP(mmHg) | 82±14 | 81±15 | 0.210 | 0.834 |
| 原发病[例(%)] | 6.775a | 0.079 | ||
| 糖尿病 | 57(32.4) | 56(41.5) | ||
| 肾小球肾炎 | 48(27.3) | 42(31.1) | ||
| 高血压 | 31(17.6) | 20(14.8) | ||
| 其他 | 40(22.7) | 17(12.6) | ||
| OH(L) | 2.84±2.06 | 3.69±2.96 | -2.969 | 0.003 |
| TBW(L) | 34.73±7.45 | 34.95±7.58 | -0.254 | 0.800 |
| ECW(L) | 17.14±3.75 | 17.48±4.16 | -0.768 | 0.443 |
| ICW(L) | 17.60±4.10 | 17.46±4.15 | 0.288 | 0.773 |
| ECW/ICW | 0.99±0.14 | 1.02±0.20 | -1.625 | 0.105 |
| LTM(kg) | 36.2±10.0 | 36.9±10.3 | -0.556 | 0.579 |
| ATM(kg) | 28.2±13.0 | 23.2±12.2 | 3.466 | 0.001 |
| FM(kg) | 20.8±9.6 | 17.1±8.9 | 3.461 | 0.001 |
| LTI(kg/m2) | 12.9±2.8 | 13.4±3.0 | -1.638 | 0.102 |
| FTI(kg/m2) | 10.3±4.9 | 8.6±4.5 | 3.158 | 0.002 |
Table 1 Comparison of baseline data between the two groups
| 项目 | MHD组(n=176) | PD组(n=135) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄(岁) | 57.8±15.1 | 57.3±16.7 | 0.251 | 0.802 |
| 性别(男/女) | 108/68 | 74/61 | 1.350a | 0.249 |
| 透析龄[M(P25,P75),月] | 17.82(10.10,32.85) | 17.00(6.00,27.00) | 1.573b | 0.014 |
| 身高(cm) | 166.7±8.5 | 165.0±8.6 | 1.695 | 0.091 |
| BW(kg) | 67.7±14.6 | 64.2±13.9 | 2.116 | 0.035 |
| TW(kg) | 64.9±14.3 | 60.5±13.4 | 2.728 | 0.007 |
| BMI(kg/m2) | 24.3±4.5 | 23.5±3.8 | 1.696 | 0.091 |
| SBP(mmHg) | 151±19 | 147±22 | 1.508 | 0.132 |
| DBP(mmHg) | 82±14 | 81±15 | 0.210 | 0.834 |
| 原发病[例(%)] | 6.775a | 0.079 | ||
| 糖尿病 | 57(32.4) | 56(41.5) | ||
| 肾小球肾炎 | 48(27.3) | 42(31.1) | ||
| 高血压 | 31(17.6) | 20(14.8) | ||
| 其他 | 40(22.7) | 17(12.6) | ||
| OH(L) | 2.84±2.06 | 3.69±2.96 | -2.969 | 0.003 |
| TBW(L) | 34.73±7.45 | 34.95±7.58 | -0.254 | 0.800 |
| ECW(L) | 17.14±3.75 | 17.48±4.16 | -0.768 | 0.443 |
| ICW(L) | 17.60±4.10 | 17.46±4.15 | 0.288 | 0.773 |
| ECW/ICW | 0.99±0.14 | 1.02±0.20 | -1.625 | 0.105 |
| LTM(kg) | 36.2±10.0 | 36.9±10.3 | -0.556 | 0.579 |
| ATM(kg) | 28.2±13.0 | 23.2±12.2 | 3.466 | 0.001 |
| FM(kg) | 20.8±9.6 | 17.1±8.9 | 3.461 | 0.001 |
| LTI(kg/m2) | 12.9±2.8 | 13.4±3.0 | -1.638 | 0.102 |
| FTI(kg/m2) | 10.3±4.9 | 8.6±4.5 | 3.158 | 0.002 |
| 项目 | MHD组(n=176) | PD组(n=135) | t(Z)值 | P值 |
|---|---|---|---|---|
| BWm(kg) | 68.4±14.7 | 63.6±13.7 | 2.910 | 0.004 |
| TWm(kg) | 66.0±14.4 | 60.4±13.0 | 3.506 | 0.001 |
| SBPm(mmHg) | 149±15 | 145±15 | 2.298 | 0.022 |
| DBPm(mmHg) | 79±11 | 80±11 | -0.648 | 0.517 |
| TBWm(L) | 34.52±7.09 | 34.31±7.35 | 0.259 | 0.796 |
| ECWm(L) | 16.86±3.36 | 16.93±3.68 | -0.184 | 0.854 |
| ICWm(L) | 17.67±4.00 | 17.38±4.02 | 0.627 | 0.531 |
| ECWm/ICWm | 0.97±0.11 | 0.99±0.13 | -1.753 | 0.081 |
| LTMm(kg) | 36.1±9.4 | 36.4±9.6 | -0.301 | 0.763 |
| ATMm(kg) | 29.6±12.3 | 23.6±10.4 | 4.483 | <0.001 |
| FMm(kg) | 21.7±9.1 | 17.4±7.7 | 4.481 | <0.001 |
| LTIm(kg/m2) | 12.8±2.6 | 13.2±2.6 | -1.463 | 0.145 |
| FTIm(kg/m2) | 10.7±4.5 | 8.7±3.8 | 4.011 | <0.001 |
| OHm[M(P25,P75),L] | 2.18(1.49,3.21) | 2.70(1.76,4.38) | 1.791a | 0.003 |
| OHsd[M(P25,P75),L] | 0.81(0.53,1.16) | 1.04(0.75,1.48) | 2.133a | <0.001 |
| OHd[M(P25,P75),L] | 2.60(1.50,4.00) | 4.00(2.90,5.80) | 3.096a | <0.001 |
| OHd/t[M(P25,P75),L/月] | 0.29(0.15,0.58) | 0.59(0.26,1.23) | 2.452a | <0.001 |
Table 2 Comparison of follow-up data between the two groups
| 项目 | MHD组(n=176) | PD组(n=135) | t(Z)值 | P值 |
|---|---|---|---|---|
| BWm(kg) | 68.4±14.7 | 63.6±13.7 | 2.910 | 0.004 |
| TWm(kg) | 66.0±14.4 | 60.4±13.0 | 3.506 | 0.001 |
| SBPm(mmHg) | 149±15 | 145±15 | 2.298 | 0.022 |
| DBPm(mmHg) | 79±11 | 80±11 | -0.648 | 0.517 |
| TBWm(L) | 34.52±7.09 | 34.31±7.35 | 0.259 | 0.796 |
| ECWm(L) | 16.86±3.36 | 16.93±3.68 | -0.184 | 0.854 |
| ICWm(L) | 17.67±4.00 | 17.38±4.02 | 0.627 | 0.531 |
| ECWm/ICWm | 0.97±0.11 | 0.99±0.13 | -1.753 | 0.081 |
| LTMm(kg) | 36.1±9.4 | 36.4±9.6 | -0.301 | 0.763 |
| ATMm(kg) | 29.6±12.3 | 23.6±10.4 | 4.483 | <0.001 |
| FMm(kg) | 21.7±9.1 | 17.4±7.7 | 4.481 | <0.001 |
| LTIm(kg/m2) | 12.8±2.6 | 13.2±2.6 | -1.463 | 0.145 |
| FTIm(kg/m2) | 10.7±4.5 | 8.7±3.8 | 4.011 | <0.001 |
| OHm[M(P25,P75),L] | 2.18(1.49,3.21) | 2.70(1.76,4.38) | 1.791a | 0.003 |
| OHsd[M(P25,P75),L] | 0.81(0.53,1.16) | 1.04(0.75,1.48) | 2.133a | <0.001 |
| OHd[M(P25,P75),L] | 2.60(1.50,4.00) | 4.00(2.90,5.80) | 3.096a | <0.001 |
| OHd/t[M(P25,P75),L/月] | 0.29(0.15,0.58) | 0.59(0.26,1.23) | 2.452a | <0.001 |
| 因变量 | 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| CVE | ECWm/ICWm | 4.060 | 1.902 | 4.554 | 0.033 | 57.974(1.393~2 413.247) |
| CAE | OHd | 0.227 | 0.078 | 8.419 | 0.004 | 1.255(1.076~1.462) |
Table 3 Multivariate Logistic regression analysis of factors influencing the occurrence of secondary endpoint events in patients of MHD group
| 因变量 | 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| CVE | ECWm/ICWm | 4.060 | 1.902 | 4.554 | 0.033 | 57.974(1.393~2 413.247) |
| CAE | OHd | 0.227 | 0.078 | 8.419 | 0.004 | 1.255(1.076~1.462) |
| 因变量 | 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| CVE | 年龄 | 0.029 | 0.011 | 6.986 | 0.008 | 1.029(1.008~1.052) |
| CAE | OHd | 0.674 | 0.189 | 12.725 | <0.001 | 1.962(1.355~2.842) |
Table 4 Multivariate Logistic regression analysis of factors influencing the occurrence of secondary endpoint events in patients of PD group
| 因变量 | 自变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|---|
| CVE | 年龄 | 0.029 | 0.011 | 6.986 | 0.008 | 1.029(1.008~1.052) |
| CAE | OHd | 0.674 | 0.189 | 12.725 | <0.001 | 1.962(1.355~2.842) |
| MHD组 | PD组 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 自变量 | β | SE | Wald χ2值 | P值 | HR(95%CI) | 自变量 | β | SE | Wald χ2值 | P值 | HR(95%CI) |
| 年龄 | 0.067 | 0.025 | 7.451 | 0.006 | 1.070(1.019~1.123) | DBPm | -0.060 | 0.027 | 5.164 | 0.023 | 0.942(0.854~0.992) |
| OHsd | 1.284 | 0.284 | 20.511 | <0.001 | 3.612(2.072~6.296) | ||||||
Table 5 Results of multivariate Cox regression analysis of influencing factors for ACM in two groups of patients
| MHD组 | PD组 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 自变量 | β | SE | Wald χ2值 | P值 | HR(95%CI) | 自变量 | β | SE | Wald χ2值 | P值 | HR(95%CI) |
| 年龄 | 0.067 | 0.025 | 7.451 | 0.006 | 1.070(1.019~1.123) | DBPm | -0.060 | 0.027 | 5.164 | 0.023 | 0.942(0.854~0.992) |
| OHsd | 1.284 | 0.284 | 20.511 | <0.001 | 3.612(2.072~6.296) | ||||||
| [1] |
2020 USRDS Annual Data Report[EB/OL]. [2022-12-07].
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [1] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
| [2] | ZHU Rongfang, JIN Jingjing, LIANG Xiangnan, QIAN Yuetong, GENG Tonghui, BAI Yaling, XU Jinsheng. Correlation between Mean Platelet Volume and Vascular Access Events in Maintenance Hemodialysis Patients [J]. Chinese General Practice, 2025, 28(15): 1855-1861. |
| [3] | ZHANG Xin, ZHU Qing, LI Nanfang. Association of Lipid Accumulation Product Index and Chronic Kidney Disease in Patients with Hypertension with Abnormal Glucose Metabolism: a Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(15): 1840-1846. |
| [4] | WANG Shihong, DENG Xingyu, CAO Rudai, LING Yao, HUANG Cuiyi, OUYANG Dong, DING Yuanlin, YU Haibing. The Trend Prediction of Five Subtypes of Chronic Kidney Disease in China from 2020 to 2040 [J]. Chinese General Practice, 2025, 28(07): 814-823. |
| [5] | ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574. |
| [6] | CHEN Ruman, BAI Yafei, WANG Chunli, AN Na, XU Mingzhi, HE Jiqing, QI Yonghui, WANG Liheng, LI Hong. Combined Predictive Value of Neutrophil-to-lymphocyte Ratio and C-reactive Protein-to-albumin Ratio for All-cause Mortality Risk in Patients with Maintenance Hemodialysis: Cohort Study Followed for 5 Years [J]. Chinese General Practice, 2024, 27(35): 4397-4402. |
| [7] | NIU Di, CHEN Ruifang, PANG Xinxin, XIAO Mingzhi, ZHANG Junshao, ZHANG Xiaowei. Correlation between Systemic Immune-inflammation Index and Erythropoietin Hypo-responsiveness in Patients with Maintenance Hemodialysis [J]. Chinese General Practice, 2024, 27(29): 3635-3640. |
| [8] | LI Qiuling, TANG Wenwu, YU Yiwen, DENG Huan, YANG Xiaohua, CHEN Xiaoxia, JI Yifei. Establishment and Verification of Risk Prediction Model for Silent Brain Infarction in Maintenance Hemodialysis Patients: a Multicenter Study [J]. Chinese General Practice, 2024, 27(26): 3232-3239. |
| [9] | WANG Xiaoxia, CAO Xuehua, LI Yan, XIONG Langyu, HU Wanqin, XIANG Feng, JIA Yu. Prevalence and Influencing Factors of Frailty in Maintenance Hemodialysis Patients in China: a Meta-analysis [J]. Chinese General Practice, 2024, 27(20): 2534-2544. |
| [10] | LI Jing, MA Leilei, WANG Guanran, JIANG Chen, XING Haitao, YANG Hongtao. Analysis of Clinical Characteristics and Influencing Factors of Gastrointestinal Dysfunction Associated with Peritoneal Dialysis in Uremia [J]. Chinese General Practice, 2024, 27(18): 2198-2204. |
| [11] | FAN Jing, WEI Shan, LI Liqiu, ZHENG Xiuli, LI Yan, NIU Jianying, WANG Ling, XU Chengyan. Investigation on the Incidence and Influencing Factors of Proteinuria and Renal Dysfunction in Community-dwelling Elderly Population [J]. Chinese General Practice, 2024, 27(09): 1048-1053. |
| [12] | ZHAO Ru, HAN Chen, HUANG Zeyu, WANG Qian, HU Jun, GE Zhijuan, BI Yan, SHEN Shanmei. Correlation of Serum Uric Acid and Serum Uric Acid/Creatinine Ratio Levels with Adverse Pregnancy Outcomes in Late Pregnancy [J]. Chinese General Practice, 2024, 27(09): 1074-1081. |
| [13] | ZHANG Aili, HOU Qiqi, HAN Quanle, ZHANG Boheng, ZHANG Jiawei, CAO Hongxia, ZHANG Chao, CHEN Shuohua, WU Shouling, LI Kangbo. Correlation between Atrial Fibrillation and the Risk of New-onset Chronic Kidney Disease in Northern Chinese Population [J]. Chinese General Practice, 2023, 26(36): 4521-4526. |
| [14] | XU Man, AN Zhuoling, ZHANG Yuhui, MA Zhuo. Current Situation of Potentially Inappropriate Medication in Older Cancer Patients and Strategies to Address It [J]. Chinese General Practice, 2023, 26(35): 4382-4387. |
| [15] | HE Mei, LI Hui, MU Lifeng, YANG Ming. Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study [J]. Chinese General Practice, 2023, 26(20): 2476-2481. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||